RxDC Reporting
What You Should Know
Under the Consolidated Appropriations Act of 2021 (CAA), most group health plans are required to submit an annual RxDC report to the Centers for Medicare & Medicaid Services (CMS). While the reporting itself is fairly technical, the goal behind it is straightforward: to give federal regulators better visibility into prescription drug costs and overall healthcare spending across employer-sponsored health plans.
What is RxDC Reporting?
RxDC stands for Prescription Drug Data Collection. Each year, health plans must submit detailed information about prescription drug spending and healthcare costs. The report includes data such as:
- Total spending on prescription drugs
- The most frequently used and most costly medications
- Premium and claims information
- Rebates and fees paid to pharmacy benefit managers
The government uses this information to better understand the drivers of rising healthcare costs and to evaluate potential policy changes aimed at controlling those costs.
Why Is It Required?
RxDC reporting was created as part of the CAA’s broader effort to increase transparency in healthcare pricing and prescription drug costs. By collecting standardized data from health plans nationwide, regulators can analyze trends and identify areas where costs may be increasing rapidly.
Who Is Responsible for Reporting?
Technically, the group health plan itself is responsible for ensuring the report is submitted each year. However, in practice, most employers rely on their insurance carrier, pharmacy benefit manager, or third-party administrator to compile and submit the required data.
Fully insured plans typically have their insurance carrier handle the reporting, while self-funded plans often rely on their TPA and PBM to submit the data on the plan’s behalf. Even when a vendor handles the filing, employers should confirm that the reporting has been completed to ensure their plan remains compliant.

In Summary
RxDC reporting was created as part of the CAA’s broader effort to increase transparency in healthcare pricing and prescription drug costs. By collecting standardized data from health plans nationwide, regulators can analyze trends and identify areas where costs may be increasing rapidly.
If you have questions about RxDC reporting or any other compliance requirements, reach out to us.


